Review on CXXC5, with data on DNA/RNA, on the protein encoded and where the gene is implicated.
Identity
Other names: CF5, RINF, WID HGNC (Hugo): CXXC5 Location: 5q31.2 Local order: From centromere to telomere: SPATA24-DNAJC18-ECSCR-TMEM173-UBE2D2-CXXC5-PSD2-NRG2. Note: Orientation on forward strand.
DNA/RNA

Description
The gene is on the plus strand and encompasses 35 kb of DNA. The exon number of gene is 3 and parts of the second and third exons encode the protein (ENSP00000302543). CXXC5 contains a nuclear localization signal adjacent to the CXXC-zinc finger domain.
Protein
Description
CXXC5 encodes a 322 amino-acid protein with a molecular mass of 33 kDa. Amino-acid sequence suggests that CXXC5 contains a number of phosphorylation and acetylation sites. By homology, CXXC5 is considered to be a member of CXXC-type zinc finger protein family, which binds to non-methylated CpG dinuclotide containing DNA.
Expression
CXXC5 is expressed in various tissues.
Localisation
CXXC5 protein is mainly in the nucleus. CXXC5 protein may also be localized in the cytoplasm coupled with Dishevelled (Dvl) protein (Andersson et al., 2009 ).
Function
CXXC5 can be induced by retinoid signaling and is required for myelopoiesis (Pendino et al., 2009 ). CXXC5 protein is involved in the DNA-damage induced p53 activation as well as in the regulation of cell cycle and apoptosis (Zhang et al., 2009 ). CXXC5 protein participates in the TNF-a-induced apoptosis through association with SMAD (Wang et al., 2013) . CXXC5 protein is a critical modulator of BMP4-regulated Wnt-signaling in neural stem cells (Andersson et al., 2009) . CXXC5 protein is shown to repress TET2 gene expression (Ko et al., 2013) .
Homology
CXXC domain is a highly conserved domain of a class of proteins that interact with non-methylated CpG dinucleotides (CpGs). The CXXC domain of CXXC5 displays a significant homology to CXXC domains of CXXC4 and TET3 proteins (Ko et al., 2013) .
Mutations
Note
Not defined yet.
Implicated in
Acute myeloid leukemia (AML) and Myelodysplastic syndrome (MDS)
Disease Acute myeloid leukemia (AML) is a disease manifested by cytogenetic anomalies affecting cell proliferation, death and differentiation (Renneville et al., 2008) . Myelodysplastic syndrome (MDS) defines a hematological condition with insufficient hematopoiesis. MDS results from chromosomal deletions, inversions and translocations giving rise to trilineage dysplasia (Mhawech and Saleem, 2001) . Oncogenesis The region on the chromosome 5 which also contains CXXC5 gene (5q31.2) is often deleted in AML and MDS (Treppendahl et al., 2013) . Low survival rate has been observed in intensive chemotherapy treated patients with AML who show a high level of CXXC5 gene expression (Astori et al., 2013) .
Acute promyelocytic leukemia (APL)
Disease APL, which is characterized by the translocation event of the retinoic acid receptor alpha gene, is a rare subtype of AML in which leukemia cells are sensitive to anthracyclines (Tallman and Altman, 2008) . Oncogenesis Terminal maturation of premyelocytic leukemia cells requires the expression of CXXC5 (Pendino et al., 2009 ).
Breast cancer
Disease Breast cancer is a disease which is mainly originated in the lining of the milk ducts and/or the lobules. Oncogenesis It has been shown that CXXC5 is transcriptionally upregulated in some solid tumors including CXXC5 (CXXC finger protein 5) Yasar P, Muyan M Atlas Genet Cytogenet Oncol Haematol. 2014; 19(1) melanoma, thyroid and breast cancer. In addition, overexpression of CXXC5 in breast cancer is suggested to be associated with poor prognosis (Knappskog et al., 2011) .
